These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 21838607
21. Efficiency of a novel middle ear pressure device for intractable definite Meniere's disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan. Nakazato A, Takakura H, Do TA, Ueda N, Takeda N, Watanabe Y, Shojaku H. Acta Otolaryngol; 2022 May; 142(5):388-394. PubMed ID: 35544580 [Abstract] [Full Text] [Related]
22. Meniett therapy: rescue treatment in severe drug-resistant Ménière's disease? Boudewyns AN, Wuyts FL, Hoppenbrouwers M, Ketelslagers K, Vanspauwen R, Forton G, Van de Heyning PH. Acta Otolaryngol; 2005 Dec; 125(12):1283-9. PubMed ID: 16303675 [Abstract] [Full Text] [Related]
23. Control of symptoms in patients with Meniere's disease using middle ear pressure applications: two years follow-up. Densert B, Sass K. Acta Otolaryngol; 2001 Jul; 121(5):616-21. PubMed ID: 11583396 [Abstract] [Full Text] [Related]
24. Meniett device for Ménière's disease: use and compliance at 3 to 5 years. Mattox DE, Reichert M. Otol Neurotol; 2008 Jan; 29(1):29-32. PubMed ID: 18199955 [Abstract] [Full Text] [Related]
25. Intratympanic gentamicin for intractable Meniere's disease. Perez N, Martín E, García-Tapia R. Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197 [Abstract] [Full Text] [Related]
29. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients. Convert C, Franco-Vidal V, Bebear JP, Darrouzet V. Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517 [Abstract] [Full Text] [Related]
30. [Local overpressure treatment reduces vestibular symptoms in patients with Menière's disease--secondary publication. A clinically randomised multicenter double-blind placebo-controlled study]. Thomsen JC, Sass K, Odkvist L, Arlinger S. Ugeskr Laeger; 2006 Jan 23; 168(4):378-80. PubMed ID: 16436239 [Abstract] [Full Text] [Related]
31. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière's disease--a clinical multicentre placebo-controlled study. Odkvist LM, Arlinger S, Billermark E, Densert B, Lindholm S, Wallqvist J. Acta Otolaryngol Suppl; 2000 Jan 23; 543():99-101. PubMed ID: 10908991 [Abstract] [Full Text] [Related]
32. Bilateral Ménière's disease. Nabi S, Parnes LS. Curr Opin Otolaryngol Head Neck Surg; 2009 Oct 23; 17(5):356-62. PubMed ID: 19617826 [Abstract] [Full Text] [Related]
33. 12-month effect of middle ear pressure therapy with the EFET01 device for intractable definite Meniere's disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan. Nakazato A, Takakura H, Ueda N, Do TA, Takeda N, Watanabe Y, Shojaku H. Acta Otolaryngol; 2022 Jun 23; 142(6):491-498. PubMed ID: 35723676 [Abstract] [Full Text] [Related]
35. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review. Li CS, Lai JT. Acta Neurochir (Wien); 2008 Jul 23; 150(7):655-61; discussion 661. PubMed ID: 18536995 [Abstract] [Full Text] [Related]